XOMA (XOMA) News Today $26.78 -0.36 (-1.33%) (As of 12:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period HC Wainwright Reiterates "Buy" Rating for XOMA (NASDAQ:XOMA)December 16 at 1:11 AM | americanbankingnews.comXoma’s Strategic Partnerships and Promising Pipeline Drive Buy RatingDecember 14, 2024 | markets.businessinsider.comXOMA's (XOMA) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $123.00 target price on shares of XOMA in a report on Friday.December 13, 2024 | marketbeat.comXOMA Co. (NASDAQ:XOMA) Shares Sold by Fmr LLCFmr LLC decreased its position in shares of XOMA Co. (NASDAQ:XOMA - Free Report) by 4.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,102,401 shares of the biotechnology company's stocDecember 10, 2024 | marketbeat.comA Glimpse Into The Expert Outlook On XOMA Royalty Through 4 AnalystsDecember 3, 2024 | benzinga.comStrategic Acquisitions and Growth Potential Bolster Xoma’s Buy RatingDecember 3, 2024 | markets.businessinsider.comXOMA Royalty Owns Economic Interest In Seralutinib With Pulmokine Purchase; Stock UpDecember 2, 2024 | markets.businessinsider.comXOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its PortfolioDecember 2, 2024 | finance.yahoo.comXOMA (XOMA) Stock Surges Amid Positive Market MovementNovember 26, 2024 | gurufocus.comTop Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 EarningsNovember 18, 2024 | benzinga.comXOMA Co. (NASDAQ:XOMA) Sees Significant Decrease in Short InterestXOMA Co. (NASDAQ:XOMA - Get Free Report) was the recipient of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 173,300 shares, a drop of 23.5% from the October 15th total of 226,400 shares. Based on an average trading volume of 22,100 shares, the days-to-cover ratio is presently 7.8 days.November 15, 2024 | marketbeat.comOwen Hughes Sells 21,881 Shares of XOMA Co. (NASDAQ:XOMA) StockNovember 14, 2024 | insidertrades.comWhat is HC Wainwright's Estimate for XOMA FY2025 Earnings?XOMA Co. (NASDAQ:XOMA - Free Report) - Investment analysts at HC Wainwright raised their FY2025 earnings estimates for XOMA in a note issued to investors on Thursday, November 7th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of $0.17 per sharNovember 11, 2024 | marketbeat.comXOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their EstimatesNovember 10, 2024 | finance.yahoo.comXOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsNovember 9, 2024 | finance.yahoo.comXOMA Royalty’s Third Quarter 2024 Financial InsightsNovember 8, 2024 | markets.businessinsider.comStrategic Positioning and Growth Potential Drive Buy Rating for XomaNovember 8, 2024 | markets.businessinsider.comXOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent ActivitiesNovember 7, 2024 | globenewswire.comXOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhyXOMA (NASDAQ:XOMA) Stock Crosses Above Two Hundred Day Moving Average - Here's WhyNovember 5, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for XOMA (NASDAQ:XOMA)HC Wainwright restated a "buy" rating and issued a $117.00 price target on shares of XOMA in a research report on Wednesday.October 23, 2024 | marketbeat.comXoma enters $15M royalty monetization arrangement with Twist BioscienceOctober 22, 2024 | markets.businessinsider.comXoma’s Strategic Partnerships and Pipeline Growth Position It as a Strong Investment OpportunityOctober 22, 2024 | markets.businessinsider.comXOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist BioscienceOctober 22, 2024 | globenewswire.comEllsworth Advisors LLC Makes New $516,000 Investment in XOMA Co. (NASDAQ:XOMA)Ellsworth Advisors LLC acquired a new stake in shares of XOMA Co. (NASDAQ:XOMA - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 19,475 shares of the biotechnology company's stock, valuedOctober 19, 2024 | marketbeat.comXOMA Stock Dips Amidst Biotech Sector DeclineOctober 3, 2024 | gurufocus.comXOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $25.91XOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $25.91September 28, 2024 | marketbeat.comXOMA Poised for Growth: FDA Approval of Miplyffa and Strategic Acquisitions Underpin Buy RatingSeptember 25, 2024 | markets.businessinsider.comZevra's MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)September 23, 2024 | globenewswire.comXOMA Royalty Declares Quarterly Preferred Stock DividendsSeptember 23, 2024 | globenewswire.comXOMA (NASDAQ:XOMA) Stock Passes Above 200 Day Moving Average of $25.74XOMA (NASDAQ:XOMA) Stock Price Passes Above 200-Day Moving Average of $25.74September 17, 2024 | marketbeat.comXOMA Royalty Corp. 8.625% Pfd. Series ASeptember 5, 2024 | wsj.comXOMA Royalty to Present at Upcoming Investor Conferences in SeptemberSeptember 4, 2024 | globenewswire.comXOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average of $25.53XOMA (NASDAQ:XOMA) Share Price Crosses Above 200-Day Moving Average of $25.53September 4, 2024 | marketbeat.comXOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average of $25.18XOMA (NASDAQ:XOMA) Stock Crosses Above 200-Day Moving Average of $25.18August 27, 2024 | marketbeat.comRisinger Affirms Buy Rating on Xoma with Increased Price Target Amid Strong Financial Performance and Unrecognized Asset PotentialAugust 16, 2024 | markets.businessinsider.comHC Wainwright Raises XOMA (NASDAQ:XOMA) Price Target to $117.00HC Wainwright boosted their target price on shares of XOMA from $74.00 to $117.00 and gave the stock a "buy" rating in a report on Thursday.August 15, 2024 | marketbeat.comXOMA (NASDAQ:XOMA) Upgraded to Hold at StockNews.comStockNews.com raised XOMA from a "sell" rating to a "hold" rating in a research note on Wednesday.August 14, 2024 | marketbeat.comXOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q2 2024August 13, 2024 | investorplace.comXOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent ActivitiesAugust 13, 2024 | globenewswire.comBMRN Aug 2024 115.000 call (BMRN240816C00115000)August 3, 2024 | finance.yahoo.comU.S. Biodefense Industry Research 2024-2030: Focus on Anthrax, Small Pox, Botulism, & Radiation/NuclearJuly 25, 2024 | finance.yahoo.comLatigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid GrowthJuly 22, 2024 | finance.yahoo.comXOMA (NASDAQ:XOMA) Stock Price Passes Above 200-Day Moving Average of $23.83XOMA (NASDAQ:XOMA) Share Price Crosses Above 200 Day Moving Average of $23.83July 17, 2024 | marketbeat.comXOMA's (XOMA) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $74.00 target price on shares of XOMA in a research report on Tuesday.July 9, 2024 | marketbeat.comXOMA Corporation: A Hold Rating With Steady Income From Preferred SharesJune 29, 2024 | seekingalpha.comXOMA (NASDAQ:XOMA) Shares Pass Above Two Hundred Day Moving Average of $22.95XOMA (NASDAQ:XOMA) Shares Pass Above Two Hundred Day Moving Average of $22.95June 25, 2024 | marketbeat.comXOMA Declares Quarterly Preferred Stock DividendsJune 20, 2024 | globenewswire.comXOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals' Sale of its Priority Review VoucherJune 12, 2024 | globenewswire.com3 Crazy Good Stocks to Buy With $500 Right NowJune 12, 2024 | investorplace.comXOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $22.10XOMA (NASDAQ:XOMA) Share Price Passes Above Two Hundred Day Moving Average of $22.10June 8, 2024 | marketbeat.com Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Is the Trump/Musk duo good for shares of TSLA? (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. XOMA Media Mentions By Week XOMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMA News Sentiment▼0.840.55▲Average Medical News Sentiment XOMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMA Articles This Week▼41▲XOMA Articles Average Week Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Myriad Genetics News Innoviva News OPKO Health News Ironwood Pharmaceuticals News Sangamo Therapeutics News Emergent BioSolutions News Codexis News Rigel Pharmaceuticals News Vanda Pharmaceuticals News Verastem News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMA) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
